Association of prealbumin with short-term and long-term outcomes in patients with acute ST-segment elevation myocardial infarction
Abstract
Prealbumin is considered to be a useful indicator of nutritional status. Furthermore, it has been found to be associated with severities and prognosis of a range of diseases. However, limited data on the association of baseline prealbumin level with outcomes of patients with acute ST-segment elevation myocardial infarction (STEMI) are available.
We analyzed 2313 patients admitted for acute STEMI between October 2013 and December 2020. In-hospital outcomes and mortality during the 49 months (interquartile range: 26–73 months) follow-up period were compared between patients with the low prealbumin level (< 170 mg/L) and those with the high prealbumin level (≥ 170 mg/L).
A total of 114 patients (4.9%) died during hospitalization. After propensity score matching, patients with the low prealbumin level than those with the high prealbumin level experienced higher incidences of heart failure with Killip class III (9.9% vs. 4.4%, P = 0.034), cardiovascular death (8.4% vs. 3.4%, P = 0.035) and the composite of major adverse cardiovascular events (19.2% vs. 10.3%, P = 0.012). Multivariate logistic regression analysis identified that the low prealbumin level (< 170 mg/L) was an independent predictor of in-hospital major adverse cardiovascular events (odds ratio = 1.918, 95% CI: 1.250–2.942, P = 0.003). The cut-off value of prealbumin level for predicting in-hospital death was 170 mg/L (area under the curve = 0.703, 95% CI: 0.651–0.754, P < 0.001; sensitivity = 0.544, specificity = 0.794). However, after multivariate adjustment of possible confounders, baseline prealbumin level (170 mg/L) was no longer independently associated with 49-month cardiovascular death. After propensity score matching, Kaplan-Meier survival curves revealed consistent results.
Decreased prealbumin level closely related to unfavorable short-term outcomes. However, after multivariate adjustment and controlling for baseline differences, baseline prealbumin level was not independently associated with an increased risk of long-term cardiovascular mortality in STEMI patients.
References
Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345−2353.
Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727−2733.
Chen YH, Huang SS, Lin SJ. TIMI and GRACE risk scores predict both short-term and long-term outcomes in Chinese patients with acute myocardial infarction. Acta Card iol Sin 2018; 34: 4−12.
Kontos MC, Lanfear DE, Gosch K, et al. Prognostic value of serial N-terminal pro-brain natriuretic peptide testing in patients with acute myocardial infarction. Am J Cardiol 2017; 120: 181−185.
Zamani P, Schwartz GG, Olsson AG, et al. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2013; 2: e003103.
Libby P. Inflammation in the atherosclerosis. Nature 2002; 420: 868−874.
Yu Q, Wang Z, Ding X. Serum prealbumin as a predictor of adverse outcomes in patients with heart failure: a systematic review and meta-analysis. Biomark Med 2022; 16: 569−575.
Zhang C, Liu P, Xia K, et al. Association of serum prealbumin with angiographic severity in patients with acute coronary syndrome. Med Sci Monit 2017; 23: 4041−4049.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581−1598.
Sgarbossa EB. Value of the ECG in suspected acute myocardial infarction with left bundle branch block. J Electr ocardiol 2000; 33: S87−S92.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604−612.
Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis 2014; 63: 820−834.
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1−39. e14.
Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994; 14: 495−533.
Ranasinghe RN, Biswas M, Vincent RP. Prealbumin: the clinical utility and analytical methodologies. Ann Clin Bi ochem 2022; 59: 7−14.
Lee JL, Oh ES, Lee RW, et al. Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review. Am J Med 2015; 128: 1023.e1−22.
Fleck A. Clinical and nutritional aspects of changes in acute-phase proteins during inflammation. Proc Nutr Soc 1989; 48: 347−354.
Yeh DD, Johnson E, Harrison T, et al. Serum levels of albumin and prealbumin do not correlate with nutrient delivery in surgical intensive care unit patients. Nutr Clin Pra ct 2018; 33: 419−425.
Zhang Z, Pereira SL, Luo M, et al. Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis. Nutrients 2017; 9: 829.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448−454.
Yamada T, Haruki S, Minami Y, et al. The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure. J Cardiol 2021; 78: 308−313.
Wang W, Ren D, Wang CS, et al. High sensitivity C-reactive protein to prealbumin ratio measurement as a marker of the prognosis in acute coronary syndrome. Sci Rep 2019; 9: 11583.
Zhou J, Hiki N, Mine S, et al. Role of prealbumin as a powerful and simple index for predicting postoperative complications after gastric cancer surgery. Ann Surg Oncol 2017; 24: 510−517.
Guan J, Holland CM, Schmidt MH, et al. Association of low perioperative prealbumin level and surgical complications in long-segment spinal fusion patients: a retrospective cohort study. Int J Surg 2017; 39: 135−140.
Xiu S, Chhetri JK, Sun L, et al. Association of serum prealbumin with risk of osteoporosis in older adults with type 2 diabetes mellitus: a cross-sectional study. Ther Adv Ch ronic Dis 2019; 10: 2040622319857361.
Qiao W, Leng F, Liu T, et al. Prognostic value of prealbumin in liver cancer: a systematic review and meta-analysis. Nutr Cancer 2020; 72: 909−916.
Zu H, Wang H, Li C, et al. Preoperative prealbumin levels on admission as an independent predictive factor in patients with gastric cancer. Medicine (Baltimore) 2020; 99: e19196.
Wang W, Pan Y, Tang X, et al. Serum prealbumin and its changes over time are associated with mortality in acute kidney injury. Sci Rep 2017; 7: 41493.
Cheng V, Inaba K, Haltmeier T, et al. Serum transthyretin is a predictor of clinical outcomes in critically ill trauma patients. Surgery 2015; 158: 438−444.
Wang W, Wang CS, Ren D, et al. Low serum prealbumin levels on admission can independently predict in-hospital adverse cardiac events in patients with acute coronary syndrome. Medicine (Baltimore) 2018; 97: e11740.
Akashi M, Minami Y, Haruki S, et al. Prognostic implications of prealbumin level on admission in patients with acute heart failure referred to a cardiac intensive care unit. J Cardiol 2019; 73: 114−119.
Franco J, Formiga F, Trullas JC, et al. Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure. Eur J Intern Med 2017; 43: 36−41.
Gok M, Kurtul A, Taylan G, et al. Serum prealbumin: a potential predictor of right ventricular dysfunction in patients receiving programmed hemodialysis. Rev Assoc Med Bras (1992) 2022; 68: 792−796.
Parent B, Seaton M, O’Keefe GE. Biochemical markers of nutrition support in critically ill trauma victims. JPEN J Parenter Enteral Nutr 2018; 42: 335−342.
京公网安备11010802044758号